{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:40:24Z","timestamp":1790998824933,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"DOI":"10.7759\/cureus.104176","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:58:51Z","timestamp":1771934331000},"source":"Crossref","is-referenced-by-count":1,"title":["Drug-Induced Cutaneous Reactions: A Clinically Oriented Review for Frontline Physicians"],"prefix":"10.7759","author":[{"given":"Ghaidaa S","family":"Elmehallawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeman A","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaima Khaled A","family":"Kurdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Rates of cutaneous reactions to drugs","volume":"137","author":"Bigby M","year":"2001","unstructured":"Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001, 137:765-70.","journal-title":"Arch Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau JC","year":"1994","unstructured":"Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994, 331:1272-85. 10.1056\/NEJM199411103311906","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000335627","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"97","author":"Harr T","year":"2012","unstructured":"Harr T, French LE. Stevens-Johnson syndrome and toxic epidermal necrolysis. Chem Immunol Allergy. 2012, 97:149-66. 10.1159\/000335627","journal-title":"Chem Immunol Allergy"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000335612","article-title":"Epidemiology of cutaneous adverse drug reactions","volume":"97","author":"Mockenhaupt M","year":"2012","unstructured":"Mockenhaupt M. Epidemiology of cutaneous adverse drug reactions. Chem Immunol Allergy. 2012, 97:1-17. 10.1159\/000335612","journal-title":"Chem Immunol Allergy"},{"key":"ref5","article-title":"Drug eruptions: approaching the diagnosis of drug-induced skin diseases","volume":"2","author":"Nigen S","year":"2003","unstructured":"Nigen S, Knowles SR, Shear NH. Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol. 2003, 2:278-99.","journal-title":"J Drugs Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung SI","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, et al.. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A. 2005, 102:4134-9. 10.1073\/pnas.0409500102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.11.017","article-title":"Adverse drug reactions and organ damage: the skin","volume":"28","author":"Marzano AV","year":"2016","unstructured":"Marzano AV, Borghi A, Cugno M. Adverse drug reactions and organ damage: the skin. Eur J Intern Med. 2016, 28:17-24. 10.1016\/j.ejim.2015.11.017","journal-title":"Eur J Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis","volume":"69","author":"Schwartz RA","year":"2013","unstructured":"Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013, 69:173.e1-13; quiz 185-6. 10.1016\/j.jaad.2013.05.003","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/all.13765","article-title":"Immune pathomechanism and classification of drug hypersensitivity","volume":"74","author":"Pichler WJ","year":"2019","unstructured":"Pichler WJ. Immune pathomechanism and classification of drug hypersensitivity. Allergy. 2019, 74:1457-71. 10.1111\/all.13765","journal-title":"Allergy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer D","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, et al.. U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol. 2016, 174:1194-227. 10.1111\/bjd.14530","journal-title":"Br J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions : a systematic review","volume":"29","author":"Hazell L","year":"2006","unstructured":"Hazell L, Shakir SA. Under-reporting of adverse drug reactions : a systematic review. Drug Saf. 2006, 29:385-96. 10.2165\/00002018-200629050-00003","journal-title":"Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1004","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update","volume":"103","author":"Phillips EJ","year":"2018","unstructured":"Phillips EJ, Sukasem C, Whirl-Carrillo M, et al.. Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. Clin Pharmacol Ther. 2018, 103:574-81. 10.1002\/cpt.1004","journal-title":"Clin Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Lerch M","year":"2018","unstructured":"Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018, 54:147-76. 10.1007\/s12016-017-8654-z","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong TA","year":"2017","unstructured":"Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017, 390:1996-2011. 10.1016\/S0140-6736(16)30378-6","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas B","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, et al.. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther. 2010, 88:60-8. 10.1038\/clpt.2009.252","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465618-drug-induced-cutaneous-reactions-a-clinically-oriented-review-for-frontline-physicians","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:58:52Z","timestamp":1771934332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465618-drug-induced-cutaneous-reactions-a-clinically-oriented-review-for-frontline-physicians"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.104176","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}